Clinical Trials in Texas

Showing 6241-6260 of 15,101 trials

Safety, Tolerability and Efficacy Study of V117957 in Subjects With Insomnia Associated With Alcohol Cessation

NCT04035200

The purpose of this study is to evaluate the safety, tolerability and efficacy of V117957 in subjects with alcohol use disorder (AUD) who experience insomnia associated with alcohol cessation, compared to placebo.

Insomnia

Imbrium Therapeutics114 participantsStarted Sep 2019

Glendale, California, United States • Riverside, California, United States • San Diego, California, United States +14 more locations

COMPLETEDPhase 355 miles

Atogepant for Prophylaxis of Migraine in Participants Who Failed Previous Oral Prophylactic Treatments.

NCT04740827

This study will assess the safety, tolerability, and efficacy of Atogepant 60 mg compared with placebo in participants with episodic migraine and who have previously failed 2 to 4 classes of oral prophylactic treatments.

Episodic Migraine

Allergan315 participantsStarted Mar 2021

Colton, California, United States • Encino, California, United States • Los Alamitos, California, United States +111 more locations

Safety, Tolerability and Efficacy Study of V117957 in Subjects With Insomnia Associated With Alcohol Cessation

Atogepant for Prophylaxis of Migraine in Participants Who Failed Previous Oral Prophylactic Treatments.

Find Trials by Condition in Texas

Safety and Tolerability Study of Suprachoroidal Injection of CLS-AX Following Anti-VEGF Therapy in Neovascular AMD

Study of Sotatercept for the Treatment of Chemotherapy Induced Anemia in Patients With Metastatic Breast Cancer (MK-7962-012)

Addressing Dementia Via Agitation-Centered Evaluation

An add-on Study to the FIGARO-DKD Study Called FIGARO-BM to Learn About the Link Between Biomarkers (Substances in the Blood Used as Indicators of Biological Processes, Disease Processes or Responses to Medication) and Finerenone in FIGARO-DKD Participants

Evaluate the Safety, Tolerability, Pharmacodynamics, and Efficacy of CNP-201 in Subjects Ages 16-35 With Peanut Allergy

Oral CF101 and Methotrexate Treatment in Rheumatoid Arthritis Patients

A Study to Compare Vincristine to Sirolimus for Treatment of High Risk Vascular Tumors

A Study of BTX-1188 in Subjects With Advanced Malignancies

Evaluating the Effects of Tasimelteon vs. Placebo on Jet Lag Type Insomnia

INCAGN01876 in Combination With Immunotherapy in Participants With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

39946-I Laser and Bevacizumab Treatment for Retinopathy of Prematurity

A Study of a Personalized Cancer Vaccine Targeting Shared Neoantigens

A Phase 1/2, Open-label, Multicenter, Dose Escalation and Expansion Study of SLC-3010 Monotherapy and in Combination

A Study of Combination Therapies With Viagenpumatucel-L (HS-110) in Patients With Non-Small Cell Lung Cancer

Study of Ipatasertib or Apitolisib With Abiraterone Acetate Versus Abiraterone Acetate in Participants With Castration-Resistant Prostate Cancer Previously Treated With Docetaxel Chemotherapy

Human Epilepsy Project 2: Resistant Focal Seizures Study

Multi-Center Pilot Study of truSculpt Device

A Pharmacokinetic Study of Mitapivat in Participants With Moderate Hepatic Impairment Compared to Matched Healthy Control Participants With Normal Hepatic Function